• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Pet Diabetes Care Market

    ID: MRFR/HC/41701-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Pet Diabetes Care Market Research Report By Product Type (Insulin, Oral Medications, Continuous Glucose Monitors, Diabetic Pet Food), By Animal Type (Dogs, Cats, Other Pets), By Distribution Channel (Veterinary Clinics, Online Stores, Pharmacies, Pet Specialty Stores), By Treatment Type (Insulin Treatment, Dietary Management, Monitoring Devices) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Pet Diabetes Care Market Infographic
    Purchase Options

    Pet Diabetes Care Market Summary

    The Global Pet Diabetes Care Market is projected to grow from 2.3 USD Billion in 2024 to 4.5 USD Billion by 2035.

    Key Market Trends & Highlights

    Pet Diabetes Care Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 6.29 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 4.5 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 2.3 USD Billion, reflecting the increasing awareness of pet diabetes management.
    • Growing adoption of advanced diabetes care products due to rising pet ownership is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.3 (USD Billion)
    2035 Market Size 4.5 (USD Billion)
    CAGR (2025-2035) 6.29%

    Major Players

    Nestle Purina PetCare, Mars Petcare, Idexx Laboratories, Merck Animal Health, Waltham Centre for Pet Nutrition, Boehringer Ingelheim, Purdue Animal Oncology, Elanco Animal Health, Vetoquinol, Ceva Sante Animale, PetCure Oncology, Hill's Pet Nutrition, Veterinary Specialty Hospital, Royal Canin, Zoetis

    Pet Diabetes Care Market Trends

    The Global Pet Diabetes Care Market is expanding with the surge in diabetes prevalence among pets along with the increasing concern of pet owners over the health of their pets. Pet owners are becoming more aware of the required nutrition and health care of their pets and hence there is a greater need for diabetes management products and services. This is further supported by the strides made in the veterinary domain, which has made accurate diagnoses and treatment more feasible and achievable.

    Another key driver is the ongoing trend of pet humanization where pets are increasingly viewed as family members leading to further expenditure in specialized diabetes care and treatment. Although market expansion is in progress, a plethora of opportunities still exists untapped.

    The emergence of mobile health apps and remote monitoring equipment can facilitate better management of pet diabetes. Innovations in this field can help develop diabetic diets and dietary supplements targeted specifically for pets. This is an area that can easily attract attention and explore the potential of specialized nutrition. It is also possible to carry out informative campaigns aimed at pet owners concerning the symptoms of diabetes, its management, and care, which will lead to a more responsible and knowledgeable society.

    Currently, new products that allow for easier monitoring and management of diabetes in pets are being launched into the market. There is increasing collaboration between vets and technology companies to develop better monitoring and management solutions for diabetes in pets, which is a sign of increased technology adoption in animal health care.

    In addition, there is a growing trend towards the use of holistic methods that incorporate natural supplements and alternative medications. By and large, these changes point to a vibrant market that is responsive to the demands and expectations of the pets and their owners, signifying a shift to more oriented ways of caring for the animals.

    The rising prevalence of diabetes among pets underscores the urgent need for enhanced management solutions and educational resources for pet owners, reflecting a growing awareness of pet health and wellness.

    U.S. Food and Drug Administration (FDA)

    Pet Diabetes Care Market Drivers

    Increase in Pet Ownership

    The surge in pet ownership globally is another significant factor propelling the Global Pet Diabetes Care Market Industry. As more households adopt pets, particularly dogs and cats, the potential for diabetes cases increases correspondingly. This trend is particularly evident in urban areas, where pet ownership rates have soared. The growing number of pets translates to a higher demand for diabetes care solutions, as owners seek to ensure their pets lead healthy lives. Consequently, the market is poised for growth, with projections indicating a market size of 2.3 USD Billion in 2024, reflecting the increasing need for diabetes management.

    Market Growth Projections

    The Global Pet Diabetes Care Market Industry is projected to experience substantial growth over the next decade. With an expected market size of 2.3 USD Billion in 2024, the industry is on a trajectory to reach 4.5 USD Billion by 2035. This growth is indicative of a compound annual growth rate of 6.29% from 2025 to 2035, reflecting the increasing demand for diabetes management products and services. Factors contributing to this growth include rising pet ownership, advancements in veterinary medicine, and heightened awareness among pet owners regarding diabetes care.

    Expansion of Pet Health Insurance

    The expansion of pet health insurance is facilitating access to diabetes care for pet owners, thereby influencing the Global Pet Diabetes Care Market Industry. As more insurance companies offer comprehensive coverage for chronic conditions like diabetes, pet owners are more likely to seek veterinary care and invest in necessary treatments. This trend is particularly relevant as it alleviates the financial burden associated with managing a diabetic pet. The anticipated growth in the market, reaching 4.5 USD Billion by 2035, suggests that insurance coverage will play a crucial role in enhancing the affordability and accessibility of diabetes care solutions.

    Growing Awareness Among Pet Owners

    There is a notable increase in awareness among pet owners regarding diabetes and its management, which is driving the Global Pet Diabetes Care Market Industry. Educational campaigns and resources provided by veterinarians and pet health organizations are empowering owners to recognize symptoms and seek timely intervention. This heightened awareness is likely contributing to the rising demand for diabetes care products, including specialized diets and insulin therapies. As pet owners become more proactive in managing their pets' health, the market is expected to experience a compound annual growth rate of 6.29% from 2025 to 2035.

    Advancements in Veterinary Medicine

    Technological advancements in veterinary medicine are significantly influencing the Global Pet Diabetes Care Market Industry. Innovations such as continuous glucose monitoring systems and advanced insulin formulations are enhancing the management of diabetes in pets. These developments not only improve the quality of life for diabetic pets but also provide pet owners with more effective tools for monitoring and treatment. As a result, the market is expected to expand, with a projected value of 4.5 USD Billion by 2035. This growth reflects the increasing reliance on sophisticated medical solutions to address pet health challenges.

    Rising Incidence of Diabetes in Pets

    The increasing prevalence of diabetes among pets is a primary driver of the Global Pet Diabetes Care Market Industry. Recent studies indicate that diabetes affects approximately 1 in 300 dogs and 1 in 100 cats, with these figures likely rising due to factors such as obesity and sedentary lifestyles. As pet owners become more aware of these health issues, the demand for diabetes management products and services is expected to grow. This trend is reflected in the projected market size, which is anticipated to reach 2.3 USD Billion in 2024, further underscoring the urgency for effective diabetes care solutions.

    Market Segment Insights

    Pet Diabetes Care Market Product Type Insights

    The Global Pet Diabetes Care Market reveals essential insights into its Product Type segment, showcasing the diversity and breadth of options available for managing diabetes in pets. In 2024, the market is set to be valued at approximately 2.3 USD Billion, with a clear emphasis on different product classifications that aid in treating diabetic pets. Among these, Insulin holds a significant portion of the market, with a valuation of 0.9 USD Billion projected for 2024 and expected to rise to 1.8 USD Billion by 2035.

    This growth is primarily driven by the increasing prevalence of diabetes in pets, demonstrating the critical role insulin plays in disease management and making it a dominant product in the market. 

    Oral Medications, valued at 0.5 USD Billion in 2024, are also essential, providing effective alternatives for pet owners who may prefer non-injection methods for their animals. This category is predicted to reach 1.0 USD Billion by 2035, reflecting growing acceptance and reliance on oral therapies as part of pet diabetes care. Continuous Glucose Monitors, valued at 0.6 USD Billion in 2024 with an expected growth to 1.3 USD Billion by 2035, is paving the way for more life-enhancing technology in pet healthcare.

    These devices enable pet owners and veterinarians to track glucose levels easily, allowing for timely interventions and better management of the condition.Conversely, Diabetic Pet Food remains a smaller segment, valued at 0.3 USD Billion in 2024 and projected to increase to 0.4 USD Billion by 2035. 

    While it sees slower growth compared to the other product types, it nevertheless contributes significantly to the comprehensive care of diabetic pets by providing specialized nutrition tailored to their needs. Each category within the Global Pet Diabetes Care Market segmentation plays a vital role, with Insulin and Oral Medications dominating the revenue landscape due to their direct impact on treatment efficacy and pet owners' choices. As the market grows, it embraces advancements in technology and tailored solutions, indicating a robust outlook for pet diabetes management in the years to come.

    Pet Diabetes Care Market Animal Type Insights

    The Global Pet Diabetes Care Market revenue reflects a growing concern for pet health, particularly among different animal types. By 2024, this market is expected to be valued at 2.3 billion USD, driven by the increasing diagnosis of diabetes in pets and rising awareness among pet owners about chronic conditions. Among the different animal types, dogs and cats dominate the market due to their high prevalence in households, accounting for a significant portion of the diagnosed diabetes cases.

    Other pets, while less common, also contribute to market dynamics, highlighting the need for specialized care products.The market segmentation allows insights into consumer preferences and the development of targeted products that meet the unique needs of these animals.

    Market growth is further supported by technological advancements in healthcare and rising disposable income among pet owners, providing new opportunities for innovative diabetes management solutions tailored to each animal type. However, the market also faces challenges, such as the cost of treatment and the continual need for education regarding pet diabetes care, which will be crucial for sustainable growth in the Global Pet Diabetes Care Market industry.Global Pet Diabetes Care Market data reveals a significant upward trend as pet owners increasingly prioritize the health and well-being of their furry companions.

    Pet Diabetes Care Market Distribution Channel Insights

    The Distribution Channel segment of the Global Pet Diabetes Care Market is vital, showcasing diverse avenues through which products and services reach customers. By 2024, the overall market is projected to scale to a value of $2.3 billion, reflecting a growing demand within this space. Veterinary Clinics serve a crucial role, providing professional diagnosis and tailored treatment options, which makes them significant in the market.

    Online Stores contribute to the convenience factor for pet owners, allowing easy access to diabetes care solutions, which is increasingly preferred in today's digital age.Pharmacies also play an essential role, offering medications and supplies that pet owners can readily obtain for managing their pets' conditions. Pet Specialty Stores dominate the market by catering specifically to pet needs, providing a wide range of products, and fostering brand loyalty among consumers.

    The dynamics of these distribution channels exhibit trends in consumer preferences, enhancing market growth as they adapt to the increasing concerns surrounding pet health and diabetes management. The challenge remains in ensuring consistent product availability and educating customers about pet diabetes care across these channels.

    Pet Diabetes Care Market Treatment Type Insights

    The Global Pet Diabetes Care Market is anticipated to reach a valuation of 2.3 billion USD by 2024, showcasing the growing importance of various treatment types to manage diabetes in pets. Among these, insulin treatment is critical as it directly addresses the hormonal imbalance in diabetic pets, facilitating better health outcomes. Dietary management also plays a pivotal role, with tailored nutrition plans enhancing overall well-being and stabilizing blood sugar levels, which ultimately supports the efficacy of other treatment methods.

    Monitoring devices are essential in this landscape, allowing pet owners to track their pet’s glucose levels regularly, contributing to timely adjustments in treatment.

    The focus on these treatment types reflects the increasing awareness among pet owners and veterinarians about the significance of comprehensive diabetes care. As the Global Pet Diabetes Care Market continues to expand, these segments will likely drive market growth, leveraging advancements in technology and improvements in pet health management protocols. The demand for effective management solutions will further shape the market dynamics, presenting ample opportunities for innovation within the industry.

    Get more detailed insights about Pet Diabetes Care Market Research Report - Forecast 2035

    Regional Insights

    The Global Pet Diabetes Care Market shows notable growth across various regions, with the overall market set to reach a valuation of 2.3 USD Billion by 2024. North America dominates the landscape, holding a significant share of 1.1 USD Billion, expected to expand to 2.1 USD Billion by 2035. This robust market presence is fueled by increasing pet ownership and rising awareness of diabetes in pets.

    Europe follows, valued at 0.7 USD Billion in 2024, presenting a substantial market opportunity due to growing health concerns for pets and an inclination towards preventive care.The APAC region, while smaller, is growing steadily from 0.4 USD Billion to 0.8 USD Billion as pet owners become more informed about diabetes management. South America and MEA, each valued at just 0.05 USD Billion in 2024, represent niche markets with potential for growth as pet healthcare awareness increases.

    These regions collectively contribute to the Global Pet Diabetes Care Market revenue, showcasing varied growth of drivers and unique challenges that shape their trajectories in the pet diabetes care industry. The significance of these diverse regional dynamics is vital in understanding overall market growth and segmentation.

    Pet Diabetes Care Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Global Pet Diabetes Care Market is witnessing significant growth due to the rising prevalence of diabetes in pets, leading to an increased focus on innovative care solutions and products tailored specifically for this condition. As pet owners become more aware of diabetes management and treatment options, companies are intensifying their efforts to develop specialized diets, medications, and monitoring tools to cater to this demand.

    The competitive landscape of this market is characterized by an array of players ranging from established brands to emerging startups, all striving to enhance their product offerings through research and development, strategic alliances, and targeted marketing campaigns. 

    The emphasis on improving pet health and extending the lives of beloved companions is underscored by the growing willingness of pet owners to invest in quality care solutions.Nestle Purina PetCare has established a strong presence in the Global Pet Diabetes Care Market with its innovative approach to pet nutrition and health management. The company focuses on creating specialized diets that cater to the nutritional needs of diabetic pets, emphasizing low glycemic index ingredients that help manage blood sugar levels.

    Nestle Purina's commitment to research and development is a notable strength, enabling them to formulate products based on the latest scientific insights into pet health and diabetes care. Their robust distribution channels and brand reputation further bolster their presence in the market, making their products both accessible and trusted among pet owners. Through educational initiatives, Nestle Purina PetCare engages pet owners in understanding their pets' health, offering resources that support diabetes management at home and enhancing customer loyalty.

    Mars Petcare, alongside its extensive product portfolio, is a key player in the Global Pet Diabetes Care Market, leveraging its expertise in animal nutrition and healthcare. The company focuses on offering a range of diabetic-friendly pet food options designed to help manage the condition effectively. Mars Petcare's strengths lie in its investment in cutting-edge research, allowing the company to continuously innovate and adapt its product offerings to meet the changing needs of pets with diabetes. Their global reach, supported by strong marketing strategies, ensures that their products are available to a wide audience.

    Additionally, Mars Petcare's dedication to animal welfare reinforces their brand image, making them a preferred choice for pet owners seeking reliable solutions to manage diabetes in their furry companions.

    Key Companies in the Pet Diabetes Care Market market include

    Industry Developments

    • Q2 2024: Merck Animal Health Launches Vetsulin® VetPen® 2, the Next Generation Insulin Pen for Diabetic Pets Merck Animal Health announced the launch of Vetsulin® VetPen® 2, an updated insulin delivery device designed to improve the management of diabetes in dogs and cats. The new device offers enhanced dosing accuracy and user-friendly features for pet owners and veterinarians.
    • Q1 2024: Zoetis Introduces AlphaTrak 3, a Next-Generation Blood Glucose Monitoring System for Pets Zoetis launched AlphaTrak 3, a new blood glucose monitoring system specifically designed for diabetic dogs and cats, featuring improved accuracy and connectivity with a mobile app for real-time data sharing with veterinarians.
    • Q2 2024: PetMed Express Appoints New Chief Executive Officer PetMed Express, a leading pet pharmacy, announced the appointment of a new CEO to drive growth and innovation in pet health solutions, including diabetes care products.
    • Q1 2024: Boehringer Ingelheim Receives EMA Approval for ProZinc® Insulin for Use in Diabetic Dogs Boehringer Ingelheim announced that the European Medicines Agency (EMA) has approved ProZinc® (protamine zinc insulin) for the treatment of diabetes mellitus in dogs, expanding its use beyond cats in the European market.
    • Q2 2024: Elanco Animal Health Announces Strategic Partnership with Pet Diabetes App Developer Elanco Animal Health entered into a partnership with a digital health company to integrate diabetes management tools for pets, aiming to improve remote monitoring and treatment adherence for diabetic animals.
    • Q1 2024: Companion Medical Launches InPen® for Veterinary Use in Pet Diabetes Management Companion Medical introduced the InPen® smart insulin pen for veterinary use, providing pet owners and veterinarians with digital insulin dosing support for diabetic dogs and cats.
    • Q2 2024: PetDx Raises $50 Million in Series B Funding to Expand Veterinary Diagnostic Solutions PetDx secured $50 million in Series B funding to accelerate the development and commercialization of advanced diagnostic tools, including solutions for early detection and management of diabetes in pets.
    • Q1 2024: Abbott Launches FreeStyle Libre for Veterinary Use in Continuous Glucose Monitoring Abbott announced the launch of its FreeStyle Libre continuous glucose monitoring system for veterinary use, enabling real-time glucose tracking for diabetic dogs and cats.
    • Q2 2024: Vetoquinol Opens New Manufacturing Facility for Veterinary Diabetes Care Products Vetoquinol inaugurated a new manufacturing facility dedicated to producing diabetes care products for pets, aiming to meet growing demand in North America and Europe.
    • Q1 2024: Nestlé Purina PetCare Launches Specialized Diet for Diabetic Cats Nestlé Purina PetCare introduced a new veterinary diet formulated specifically for the nutritional management of diabetes in cats, available through veterinary clinics.
    • Q2 2024: Hill's Pet Nutrition Announces Launch of Prescription Diet m/d GlucoSupport for Diabetic Dogs Hill's Pet Nutrition launched Prescription Diet m/d GlucoSupport, a new therapeutic food designed to help manage blood glucose levels in diabetic dogs.
    • Q1 2024: Bayer Animal Health Partners with Veterinary Telemedicine Platform to Enhance Diabetes Care Bayer Animal Health formed a partnership with a leading veterinary telemedicine provider to offer remote diabetes management support for pet owners and veterinarians.

    Future Outlook

    Pet Diabetes Care Market Future Outlook

    The Pet Diabetes Care Market is projected to grow at a 6.29% CAGR from 2024 to 2035, driven by rising pet ownership, increased awareness, and advancements in diabetes management technologies.

    New opportunities lie in:

    • Develop innovative insulin delivery systems tailored for pets.
    • Launch specialized dietary products targeting diabetic pets' nutritional needs.
    • Implement telehealth solutions for remote monitoring of diabetic pets.

    By 2035, the Pet Diabetes Care Market is expected to be robust, reflecting significant advancements and increased consumer investment.

    Market Segmentation

    Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Pet Diabetes Care Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Pet Diabetes Care Market Animal Type Outlook

    • Dogs
    • Cats
    • Other Pets

    Pet Diabetes Care Market Product Type Outlook

    • Insulin
    • Oral Medications
    • Continuous Glucose Monitors
    • Diabetic Pet Food

    Pet Diabetes Care Market Treatment Type Outlook

    • Insulin Treatment
    • Dietary Management
    • Monitoring Devices

    Pet Diabetes Care Market Distribution Channel Outlook

    • Veterinary Clinics
    • Online Stores
    • Pharmacies
    • Pet Specialty Stores

    Report Scope

    Attribute/Metric Source: Details
    MARKET SIZE 2023 2.17(USD Billion)
    MARKET SIZE 2024 2.3(USD Billion)
    MARKET SIZE 2035 4.5(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.27% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Nestle Purina PetCare, Mars Petcare, Idexx Laboratories, Merck Animal Health, Waltham Centre for Pet Nutrition, Boehringer Ingelheim, Purdue Animal Oncology, Elanco Animal Health, Vetoquinol, Ceva Sante Animale, PetCure Oncology, Hill's Pet Nutrition, Veterinary Specialty Hospital, Royal Canin, Zoetis
    SEGMENTS COVERED Product Type, Animal Type, Distribution Channel, Treatment Type, Regional
    KEY MARKET OPPORTUNITIES Rising pet diabetes prevalence, Increasing pet ownership, Growth in pet healthcare spending, Innovations in diabetes management products, Expansion of telehealth services for pets
    KEY MARKET DYNAMICS Increasing pet obesity rates, Rising pet ownership trends, Advancements in veterinary technology, Growing awareness of pet health, Expanding pet care expenditures
    COUNTRIES COVERED North America, Europe, APAC, South America, MEA

    FAQs

    What is the expected market size of the Global Pet Diabetes Care Market in 2024?

    The Global Pet Diabetes Care Market is expected to be valued at 2.3 USD Billion in 2024.

    What is the projected market size for the Global Pet Diabetes Care Market in 2035?

    The market is projected to reach 4.5 USD Billion by 2035.

    What is the expected CAGR for the Global Pet Diabetes Care Market from 2025 to 2035?

    The expected CAGR for the market from 2025 to 2035 is 6.27%.

    What region dominates the Global Pet Diabetes Care Market in 2024?

    In 2024, North America dominates the market with a value of 1.1 USD Billion.

    How much is the Global Pet Diabetes Care Market in Europe projected to be worth in 2035?

    The market in Europe is projected to be worth 1.4 USD Billion in 2035.

    What are the expected values of Insulin in the Global Pet Diabetes Care Market for 2024 and 2035?

    Insulin is expected to be valued at 0.9 USD Billion in 2024 and 1.8 USD Billion in 2035.

    Who are the key players in the Global Pet Diabetes Care Market?

    Major players include Nestle Purina PetCare, Mars Petcare, Idexx Laboratories, and Merck Animal Health.

    What is the expected value of Continuous Glucose Monitors in 2024?

    The expected value of Continuous Glucose Monitors in 2024 is 0.6 USD Billion.

    What challenges are anticipated for the Global Pet Diabetes Care Market going forward?

    Challenges include rising treatment costs and access to specialized veterinary care.

    How is the market expected to grow in the Asia-Pacific region by 2035?

    The Asia-Pacific region is expected to grow to 0.8 USD Billion by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials